BOSTON, May 20 PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Thursday, June 3, 2010, from 8:30 a.m. to 12:30 p.m. (EDT).
Advertisement
All interested parties are invited to listen as Chairman and Chief Executive Officer Josef von Rickenbach, Chief Financial Officer Jim Winschel and four additional members of the executive team provide a strategic overview of the Company's businesses through a series of presentations, followed by a question-and-answer session. The live webcast can be accessed in the Investor Relations section of the Company's website at www.PAREXEL.com. For those unable to listen to the live presentations, the event will be archived and available on the Company's website.
Advertisement
About the Company
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 9,500 employees. For more information about PAREXEL International visit www.PAREXEL.com.
CONTACT: Jill Baker, Vice President of Investor Relations +1-781-434-4118
SOURCE PAREXEL International Corporation
